QTTB Q2 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$121,000

Operating Income

-$18M

Net Income

-$17M

EPS (Diluted)

$-1.42

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$124M

Total Liabilities

$91M

Stockholders' Equity

$34M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$3M	-100.0%
Gross Profit	-$121,000	$3M	-103.9%
Operating Income	-$18M	-$7M	-146.3%
Net Income	-$17M	-$6M	-192.4%